Evidence map›Paper›PMID 24832205›Full record

ArticlePLoS pathogens2014

T cell inactivation by poxviral B22 family proteins increases viral virulence.

Dina Alzhanova, Erika Hammarlund, Jason Reed, Erin Meermeier, Stephanie Rawlings, Caroline A Ray, David M Edwards, Ben Bimber, Alfred Legasse, Shannon Planer and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Comprehensive literature review of monkeypox.Emerging microbes & infections · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Dina AlzhanovaVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Erika HammarlundDivision of Neuroscience, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Jason ReedVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Erin MeermeierDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America; Portland Veterans Administration Medical Center, Portland, Oregon, United States of America.
Stephanie RawlingsVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Caroline A RayDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
David M EdwardsVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Ben BimberDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Alfred LegasseDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Shannon PlanerDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Jerald SpragueVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Michael K AxthelmVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
David J PickupDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
David M LewinsohnDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America; Portland Veterans Administration Medical Center, Portland, Oregon, United States of America.
Marielle C GoldDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America; Portland Veterans Administration Medical Center, Portland, Oregon, United States of America.
Scott W WongVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Jonah B SachaVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Mark K SlifkaDivision of Neuroscience, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Klaus FrühVaccine and Gene Therapy Institute, Oregon National Primate Research Center, Portland, Oregon, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Oregon National Primate Research Center · USPortland VA Medical Center · USDuke Medical Center · USDuke University Hospital · USOregon Health & Science University · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
T Cell Control by Cowpoxvirus U19AI109948 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2014 to 2018
$6.4M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cassandra Cullin · 2013 to 2026
$6.0M
Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Mechanisms of recognition by Mycobacterium tuberculosis-reactive thymocytesR01AI078965 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOLD, MARIELLE C. · 2010 to 2013
$1.1M
NHLBI NIH HHS T32 HL083808NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI078965NIAID NIH HHS U19 AI109948NIAID NIH HHS U19AI109948NIH HHS P51 OD011092NIH HHS P51OD011092NIH HHS U42 OD010426
6 · The paper itself

Abstract

Infections with monkeypox, cowpox and weaponized variola virus remain a threat to the increasingly unvaccinated human population, but little is known about their mechanisms of virulence and immune evasion. We now demonstrate that B22 proteins, encoded by the largest genes of these viruses, render human T cells unresponsive to stimulation of the T cell receptor by MHC-dependent antigen presentation or by MHC-independent stimulation. In contrast, stimuli that bypass TCR-signaling are not inhibited. In a non-human primate model of monkeypox, virus lacking the B22R homologue (MPXVΔ197) caused only mild disease with lower viremia and cutaneous pox lesions compared to wild type MPXV which caused high viremia, morbidity and mortality. Since MPXVΔ197-infected animals displayed accelerated T cell responses and less T cell dysregulation than MPXV US2003, we conclude that B22 family proteins cause viral virulence by suppressing T cell control of viral dissemination.

Indexed as

Immune EvasionAnimalsCells, CulturedChlorocebus aethiopsCHO CellsCricetinaeCricetulusFemaleHEK293 CellsHumansJurkat CellsMacaca mulattaMiceMice, Inbred BALB CMpox, MonkeypoxPoxviridaeViral Proteins

Identifiers

PMID24832205
PMCPMC4022744
OpenAlexW2036308948

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.